Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
62.92
-1.42 (-2.21%)
At close: Jun 26, 2026, 4:00 PM EDT
62.89
-0.03 (-0.05%)
Pre-market: Jun 29, 2026, 4:39 AM EDT
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $2.71 billion as of June 29, 2026. Its market cap has increased by 57.31% in one year.
Market Cap
2.71B
Enterprise Value
2.41B
1-Year Change
57.31%
Ranking
Category
Stock Price
$62.92
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $2.71B, an increase of 778.51%. That is a compound annual growth rate of 46.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 2.71B | -22.12% |
| Dec 31, 2025 | 3.48B | 64.21% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vera Therapeutics | 3.05B |
| Ultragenyx Pharmaceutical | 3.02B |
| Disc Medicine | 2.86B |
| Celldex Therapeutics | 2.77B |
| Kailera Therapeutics | 2.70B |
| Trevi Therapeutics | 2.58B |
| MBX Biosciences | 2.49B |
| Biohaven | 2.38B |